ARTICLE | Clinical News
Anti-estrogen compounds regulatory update
February 20, 2001 8:00 AM UTC
AVXT received U.S. Patent No. 6,136,845 covering the combination of anti-estrogen alkyl polychlorodibenzofurans (PCDFs) and tamoxifen to treat estrogen-dependent tumors. ...